Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nauru Business Journal.
Press releases published on May 16, 2025

4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …

Orange County Bancorp, Inc. Declares Cash Dividend
MIDDLETOWN, N.Y., May 16, 2025 (GLOBE NEWSWIRE) -- Orange County Bancorp, Inc. (Nasdaq: OBT), parent company of Orange Bank …

MASTERBEEF GROUP Announces Closing of Partial Exercise of Over-Allotment Option in its Initial Public Offering
Hong Kong, May 16, 2025 (GLOBE NEWSWIRE) -- MasterBeef Group (the “Company”), a full-service restaurant group in Hong Kong, specializing in Taiwanese hotpot and Taiwanese barbecue, today announced today that it has issued an additional 155,000 ordinary …

Heidmar Announces the Availability of Its 2024 Annual Report on Form 20-F
ATHENS, Greece and NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Heidmar Maritime Holdings Corp. (the "Company" or "Heidmar") (NASDAQ: HMR), today announced that its annual report on Form 20-F (the “Annual Report”), which includes the Company’s audited …

AirNet Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency
BEIJING, May 16, 2025 (GLOBE NEWSWIRE) -- AirNet Technology Inc. ("AirNet" or the "Company") (Nasdaq: ANTE), today announced that on May 13, 2025, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock …

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

MGPI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MGP Ingredients, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

CODI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Diversified Holdings Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

The Nike NFTs INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nike-themed non-fungible tokens ("NFTs") Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

SEI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Solaris Energy Infrastructure, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

SOUN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SoundHound AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, May 16, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in …

IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 15, 2025 it granted stock options to purchase an aggregate of 40,275 shares of common stock and 27,144 restricted stock …

SolicitorQualification.co.uk Launches to Offer Practice SQE Questions to Support Aspiring Solicitors
Stockport, Manchester, May 16, 2025 (GLOBE NEWSWIRE) -- SolicitorQualification.co.uk, a pioneering online platform dedicated to supporting aspiring solicitors in England and Wales, has officially launched, providing comprehensive practice questions to help …

Washington Never Talked About It—But a $150 Trillion U.S. Asset May Now Be the Center of Trump’s New Energy Push, Says Former CIA Insider
WASHINGTON, D.C. , May 16, 2025 (GLOBE NEWSWIRE) -- Ask most Americans where the next breakthrough in energy relief will come from, and you’ll likely hear the same tired answers: OPEC deals, tax rebates, fuel economy tweaks. But former CIA advisor Jim …

Compass Diversified (CODI) Faces Securities Class Action After Admitting to Accounting “Irregularities” – Hagens Berman
SAN FRANCISCO, May 16, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Compass Diversified (NYSE: CODI) and certain of its executives after the company disclosed that it would restate its 2024 financial statements due to …

Investigation Announcement: Wolf Haldenstein Adler Freeman & Herz LLP Investigates Cal-Maine Foods Inc.
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman …